Enlarged Prostate and BPH: Symptoms, Tests and Treatment
Author: Ian C. Langtree - View Credentials
Published: 21 Jul 2010 - Updated: 1 Nov 2026
Publication Type: Informative
Table of Contents:
Synopsis - Definition - Overview - FAQs - Insights, Updates - Related Content
Synopsis
This information explains how the prostate works and why it causes so many problems as men age, covering benign prostatic hyperplasia, prostatitis and prostate cancer in one place. Drawing on current guidance from the American Cancer Society, the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases and the U.S. Preventive Services Task Force, it sets out the warning signs of an enlarged prostate, what a PSA result really means, who should consider screening and when, and the full range of exams from the digital rectal exam to MRI and biopsy. It replaces older one-size-fits-all advice with the shared decision approach now recommended, which is especially useful for seniors, men with a family history of the disease, Black men who face higher risk, and men with mobility impairments for whom frequent nighttime bathroom trips can pose real challenges.
At a Glance
- 1 - Prostatitis, not BPH, is the most common prostate problem in men younger than 50.
- 2 - A prostate biopsy usually takes about 10 minutes and collects around 12 tissue samples.
- 3 - The lowest Gleason score given to a cancer today is 6, which falls into Grade Group 1 on the newer five-group scale.
- 4 - Only about a quarter of men biopsied because of a raised PSA turn out to have prostate cancer. Infection, recent ejaculation and even cycling can push PSA levels up.
Topic Definition
- Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH), also called an enlarged prostate or benign prostatic hypertrophy, is a noncancerous increase in the size of the prostate gland that becomes more common with age. Because the prostate surrounds the urethra just below the bladder, the growing gland can narrow the urethra and cause lower urinary tract symptoms such as a weak or interrupted stream, difficulty starting urination, frequent or urgent urination, nighttime urination and a sense of incomplete emptying. BPH does not turn into prostate cancer, although the two conditions can occur together and cause similar symptoms. It is managed with watchful waiting, lifestyle changes, medicines, minimally invasive procedures or surgery, depending on how severe the symptoms are.
Overview
Prostate problems are among the most common health issues men face as they age. Benign prostatic hyperplasia (BPH), the noncancerous enlargement of the gland, affects an estimated 5 to 6 percent of men aged 40 to 64 and 29 to 33 percent of men aged 65 and older [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]. Prostate cancer is also common: apart from skin cancer, it is the most frequently diagnosed cancer in American men, and it is the second-leading cause of cancer death in men after lung cancer [American Cancer Society, 2026a]. Even so, many men know very little about what the prostate does or which changes deserve a visit to the doctor.
Where the Prostate Is and What It Does
The prostate is a walnut-shaped gland that sits just below the bladder and in front of the rectum. It surrounds the urethra, the tube that carries urine from the bladder out through the penis [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-b]. The prostate is part of the male reproductive system. It makes a fluid that mixes with sperm from the testicles and fluid from the two seminal vesicles to form semen, which leaves the body through the urethra during ejaculation.
The gland doubles in size early in puberty, and a second, slower phase of growth begins at around age 25 and continues for most of a man's life [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]. This lifelong growth is the reason prostate problems become more likely with age.
Common Prostate Problems
The three main conditions that affect the prostate are prostatitis, BPH and prostate cancer [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-b].
- Prostatitis is inflammation or swelling of the prostate, sometimes caused by infection. It is the most common prostate problem in men younger than 50, and it is not cancer.
- Benign prostatic hyperplasia is noncancerous enlargement of the prostate. It is the most common prostate problem in men over 50 and rarely causes symptoms before age 40.
- Prostate cancer develops when cells in the prostate grow out of control. Many prostate cancers grow slowly, but some are aggressive and spread.
BPH is sometimes called benign prostatic hypertrophy or simply an enlarged prostate. BPH and prostate cancer are separate conditions, but they can cause similar urinary symptoms, and a man can have both at the same time. That overlap is one of the main reasons urinary changes should be checked by a doctor rather than assumed to be part of getting older.
Symptoms of an Enlarged Prostate
Because the prostate surrounds the urethra, an enlarging gland can squeeze the tube and slow the flow of urine. Symptoms usually come on gradually and may include [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]:
- Trouble starting to urinate, or needing to strain.
- A weak or interrupted urine stream.
- Dribbling at the end of urination.
- A feeling that the bladder has not emptied fully.
- Needing to urinate often, or urgently.
- Waking up at night to urinate (nocturia).
- Pain during urination.
For many men these symptoms are mild and manageable. For others, they disrupt sleep, work and social life. Frequent or urgent trips to the bathroom, especially at night, can be harder and riskier for older men and for men who use a wheelchair, walker or other mobility aid, so it is worth raising them with a doctor early.
Why Urinary Symptoms Should Not Be Ignored
There are two good reasons to see a doctor when urinary symptoms appear. First, untreated BPH can lead to complications, including urinary retention (being unable to empty the bladder), blood in the urine, urinary tract infections, bladder stones and kidney damage [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]. A burning feeling when urinating, fever, blood in the urine or being unable to pass urine at all needs prompt medical attention.
Second, prostate cancer and other conditions can cause similar symptoms. Early prostate cancer often causes no symptoms at all, so a man who puts urinary changes down to normal aging may miss the chance to have cancer found early. When prostate cancer is found while still confined to the prostate or nearby tissue, the 5-year relative survival rate is more than 99 percent, compared with 38 percent once it has spread to distant parts of the body [American Cancer Society, n.d.-d].
Prostate Cancer by the Numbers
The American Cancer Society estimates about 333,830 new prostate cancer cases and about 36,320 deaths from the disease in the United States in 2026. About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and about 1 in 49 will die of it. About 6 in 10 cases are diagnosed in men 65 or older, the average age at diagnosis is about 68, and the disease is rare in men under 40 [American Cancer Society, 2026a].
New cases rose about 3 percent per year from 2014 to 2022, with the steepest rise in advanced-stage diagnoses. Black men are nearly 70 percent more likely to be diagnosed with prostate cancer and twice as likely to die from it as White men. More than 3.5 million American men who have been diagnosed with prostate cancer are alive today [American Cancer Society, 2026b].
Understanding the PSA Test
The prostate-specific antigen test, or PSA test, is a simple blood test. PSA is a protein made by both normal and cancerous cells of the prostate, and PSA screening came into wide use in the late 1980s [National Cancer Institute, n.d.].
There is no single normal PSA level. In general, the higher the level, the more likely prostate cancer is present. A level above 4.0 ng/mL has traditionally been treated as abnormal, though some doctors use a lower cutoff for younger men and a higher one for older men. PSA can also rise for reasons other than cancer, including BPH, prostatitis, infection, a recent biopsy, ejaculation and vigorous exercise such as cycling. Medicines used to treat BPH, such as finasteride and dutasteride, lower PSA levels, so doctors adjust how they read the results [National Cancer Institute, n.d.].
Men with a PSA level between 4 and 10 ng/mL have about a 1 in 4 chance of having prostate cancer, and up to half of those cancers are low grade and may not need treatment [American Cancer Society, n.d.-c]. Only about 25 percent of men who have a biopsy because of a raised PSA turn out to have prostate cancer [National Cancer Institute, n.d.]. Doctors may also look at the percentage of PSA that is free rather than bound to blood proteins, or at how PSA changes over time, when deciding whether more testing is needed.
Who Should Be Screened and When
Annual PSA testing for every man is no longer the standard advice, because screening has both benefits and harms. The harms include false-positive results, unnecessary biopsies and overdiagnosis - finding slow-growing cancers that would never have caused problems, then treating them with surgery or radiation that can lead to erectile dysfunction or incontinence [National Cancer Institute, n.d.].
The U.S. Preventive Services Task Force recommends that men aged 55 to 69 make an individual decision about PSA screening after talking with their clinician, and it recommends against routine screening for men 70 and older [U.S. Preventive Services Task Force, 2018]. The American Cancer Society recommends that men have this conversation [American Cancer Society, n.d.-a]:
- At age 50 for men at average risk who are expected to live at least 10 more years.
- At age 45 for men at high risk, including Black men and men whose father or brother was diagnosed before age 65.
- At age 40 for men at even higher risk, such as those with more than one first-degree relative diagnosed at an early age.
If screening finds no cancer, the American Cancer Society suggests retesting every 2 years for men with a PSA below 2.5 ng/mL and yearly for men at 2.5 ng/mL or higher [American Cancer Society, n.d.-a]. Men who carry inherited gene changes linked to prostate cancer may also want to discuss genetic testing and earlier screening. The right choice depends on age, health, family history and personal values, and it should be made with a doctor.
Tests Used to Check the Prostate
Depending on symptoms and PSA results, a doctor may use one or more of the following tests [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a; American Cancer Society, n.d.-c].
Digital Rectal Exam (DRE)
In a digital rectal exam, the doctor feels the prostate with a gloved, lubricated finger to check its size and look for lumps or hard areas. The American Cancer Society lists the DRE as an optional part of screening alongside the PSA test [American Cancer Society, n.d.-a].
Urinalysis
A urine test checks for infection, blood in the urine and other conditions that can cause urinary symptoms similar to those of BPH.
Urodynamic Tests
These tests measure how well the bladder and urethra store and release urine. They can include measuring the speed and strength of the urine stream and measuring how much urine stays in the bladder after urinating, which shows whether an enlarged prostate is blocking flow.
Transrectal Ultrasound
A small probe placed in the rectum uses sound waves to make images of the prostate. It shows the size of the gland, helps doctors calculate PSA density and is used to guide biopsy needles.
Prostate MRI
A multiparametric MRI scan can help decide whether a biopsy is needed and can show suspicious areas to target. Results are reported on the PI-RADS scale from 1, meaning clinically significant cancer is very unlikely, to 5, meaning it is very likely [American Cancer Society, n.d.-c]. Researchers are also studying how MRI can help stage prostate cancer.
Cystoscopy
A thin, lighted tube with a lens is passed through the urethra so the doctor can look directly at the urethra and bladder.
Newer Blood and Urine Tests
Tests such as the Prostate Health Index, the 4Kscore and IsoPSA blood tests, and urine tests such as PCA3, can help doctors decide who needs a biopsy. None has yet been shown to lower the risk of dying from prostate cancer [National Cancer Institute, n.d.]. Research continues into a urine test that identifies high-grade prostate cancer and could reduce unnecessary biopsies.
Biopsy Is the Only Way to Diagnose Prostate Cancer
PSA tests, a DRE and imaging can suggest that cancer may be present, but only a prostate biopsy can confirm it. A biopsy is usually done by a urologist in the office and takes about 10 minutes. Using ultrasound guidance, and often MRI images fused with the ultrasound, the doctor uses a thin, hollow needle to remove small tissue samples, most often about 12 cores from different parts of the prostate. The needle passes either through the wall of the rectum (transrectal) or through the skin between the scrotum and anus (transperineal) [American Cancer Society, n.d.-c].
Antibiotics are usually given to lower the risk of infection. For a few days afterward, men may have some soreness and blood in the urine, and blood or a rust color in the semen can last for several weeks [American Cancer Society, n.d.-c].
Gleason Scores and Grade Groups
A pathologist examines the tissue under a microscope. Normal prostate cells are similar in size and arranged in an orderly pattern, while cancer cells look more irregular. Using the system developed by pathologist Donald Gleason, the pathologist assigns a grade from 1 to 5 to the two most common patterns in the tumor and adds them together. In practice, almost all prostate cancers are graded 3 or higher, so the lowest Gleason score assigned to a cancer today is 6 (3+3) [American Cancer Society, n.d.-b].
Because Gleason scores can be confusing, pathologists now also report a Grade Group from 1 to 5 [American Cancer Society, n.d.-b]:
- Grade Group 1: Gleason score 6 or lower.
- Grade Group 2: Gleason score 3+4=7.
- Grade Group 3: Gleason score 4+3=7.
- Grade Group 4: Gleason score 8.
- Grade Group 5: Gleason score 9 or 10.
The higher the Grade Group, the more likely the cancer is to grow and spread quickly. Many men with Grade Group 1 cancer can safely choose active surveillance, with regular PSA tests, exams and repeat biopsies or MRI scans instead of immediate treatment.
Treatment Options for an Enlarged Prostate
Treatment for BPH depends on how much the symptoms bother a man, his overall health and the size of the prostate. Options include [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]:
- Watchful waiting and lifestyle changes, such as drinking less before bedtime or going out, cutting back on alcohol and caffeine, and taking time to empty the bladder fully.
- Alpha blockers, which relax the muscles of the bladder neck and prostate to improve urine flow.
- 5-alpha reductase inhibitors, which shrink the prostate or slow its growth. Combining one of these with an alpha blocker may work better than either alone.
- PDE5 inhibitors, which can relieve some urinary symptoms.
- Minimally invasive procedures, such as water vapor (steam) therapy and prostatic urethral lift implants that hold the enlarged tissue away from the urethra.
- Surgery, including transurethral resection, laser surgery, electrovaporization and robotic surgery, which removes or destroys excess prostate tissue.
Surgery can relieve symptoms but may not cure BPH, and about 10 percent of men who have surgery may need another operation within 20 years [National Institute of Diabetes and Digestive and Kidney Diseases, n.d.-a]. Treatment for prostate cancer is a separate decision that depends on the cancer's stage, Grade Group and the man's health, and can range from active surveillance to surgery, radiation, hormone therapy and newer targeted treatments. Anyone with urinary symptoms or concerns about prostate cancer should talk with a doctor or urologist about the options that suit them.
Frequently Asked Questions
How long should I avoid ejaculation and exercise before a PSA test?
Because ejaculation and vigorous exercise such as cycling can temporarily raise PSA, men are generally advised to avoid them for about 2 days before the blood test. Tell your doctor about any recent urinary infection or prostate procedure, as these can also affect the result.
Is a prostate biopsy painful?
Most men feel pressure and brief stinging rather than severe pain. Doctors usually numb the area with a local anesthetic, and some offer sedation, so ask what pain control will be used before the procedure.
Is a transperineal biopsy safer than a transrectal biopsy?
A transperineal biopsy passes the needle through the skin rather than the rectal wall, which is linked to a lower risk of infection. Many urology centers are moving toward this approach, but the best method depends on your anatomy, health and the equipment available.
Can men with mobility impairments have a rectal exam or prostate biopsy?
Yes. Exams and biopsies can usually be done in different positions, including lying on the side or on the back, and staff can help with transfers from a wheelchair. Let the clinic know your needs ahead of time so they can book an accessible room and extra time.
Can BPH medicines affect sexual function?
Some can. Alpha blockers may reduce or change ejaculation, and 5-alpha reductase inhibitors can lower sex drive or cause erection and ejaculation problems in some men. Discuss any side effects with your doctor rather than stopping a medicine on your own.
What is PSA density?
PSA density is the PSA level divided by the volume of the prostate, usually measured by ultrasound or MRI. Because a large prostate makes more PSA, a higher density suggests cancer is more likely than enlargement alone.
Can cold and allergy medicines make an enlarged prostate worse?
Yes. Decongestants and some antihistamines can tighten the muscles around the bladder neck or weaken bladder contractions, making it harder to pass urine. Men with BPH should check with a pharmacist or doctor before taking them.
Does saw palmetto help an enlarged prostate?
Saw palmetto is a popular supplement for BPH, but well-designed clinical trials have not shown that it improves urinary symptoms better than a placebo. Talk with your doctor before taking any supplement, as some can interact with other medicines.
References
- American Cancer Society. (n.d.-a). American Cancer Society recommendations for prostate cancer early detection. Retrieved October 27, 2026.
- American Cancer Society. (n.d.-b). Understanding your pathology report: Prostate cancer. Retrieved October 27, 2026.
- American Cancer Society. (n.d.-c). Tests to diagnose and stage prostate cancer. Retrieved October 27, 2026.
- American Cancer Society. (n.d.-d). Survival rates for prostate cancer. Retrieved October 27, 2026.
- American Cancer Society. (2026a). Key statistics for prostate cancer.
- American Cancer Society. (2026b, September 1). Prostate Cancer Awareness Month: American Cancer Society reports new cases are up 3% but earlier diagnosis improves patient outcomes [Press release].
- National Cancer Institute. (n.d.). Prostate-specific antigen (PSA) test. Retrieved October 27, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.-a). Enlarged prostate (benign prostatic hyperplasia). Retrieved October 27, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.-b). Prostate problems. Retrieved October 27, 2026.
- U.S. Preventive Services Task Force. (2018). Final recommendation statement: Screening for prostate cancer.
More on this topic: Prostate Cancer Publications - Male Health Publications - Aging Publications
Insights, Analysis, and Developments
Editorial Note: Prostate health has moved away from simple rules such as a single normal PSA number or a yearly test for every man, and toward a more personal approach that weighs age, family history, race and overall health. That shift matters because about 1 in 8 American men will be diagnosed with prostate cancer, advanced-stage cases have been climbing, and survival is far higher when the disease is caught before it spreads. At the same time, BPH remains a quality-of-life issue that is often undertreated, even though medicines, minimally invasive procedures and surgery can bring real relief. The practical message for men, their partners and caregivers is the same either way: urinary changes are worth a conversation with a doctor, and the decision about screening is best made with clear information rather than left to chance.
Author Credentials: Ian C. Langtree is a writer, editor, and the founder and Editor-in-Chief of Disabled World, which he established in 2004 as one of the longest-running independent resources for disability news and information. Over more than two decades, he has written and edited thousands of articles on disability rights, health, accessibility, and assistive technology. Drawing on a global perspective shaped by extensive travel and lived experience, Ian is a committed advocate of the Social Model of Disability, the framework developed by disabled activists in the 1970s that focuses on removing societal barriers rather than on individual impairments. His writing is grounded in that framework and in a lasting commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.